Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Merck Zocor, one of the biggest-selling drugs of all time, is set to lose up to 90% of its UK sales overnight following the introduction of generic...
New trial data on AstraZeneca's blood pressure treatment Atacand could give the drug a lead over rivals in the same class and a significant boost to...
Pharmaceutical companies in the UK have responded to the humanitarian crisis in post-war Iraq by sending over 60 tonnes of emergency medicines in the...
Femara heralded as breakthrough in breast cancer
Thousands of patients have yet to benefit from an innovative scheme to increase access to multiple sclerosis drugs, more than a year after it was...
AstraZeneca lung cancer drug Iressa has gained US approval after an extended review found the drug to be safe, despite cases of serious and sometimes...
GlaxoSmithKline is to drop claims on patient information leaflets that its antidepressant Seroxat is not addictive.
Generic competition to Losec limited AstraZeneca sales growth in the first quarter although strong growth of other products has indicated underlying...
GlaxoSmithKline has posted 11% growth in the first quarter of 2003 despite generic competition for its blockbuster antibiotic Augmentin.
OTC omeprazole to become Glaxo's next generation Zantac
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches